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Enterococcus faecalis (n = 834) and Enterococcus faecium (n = 135) from blood and
feces of hospitalized humans, from feces of outpatients and livestock and from
food were screened for their susceptibility to a quaternary ammonium compound
(didecyldimethylammoniumchloride, DDAC) and to 28 antibiotics by micro-/macrodilution.
The maximum DDAC-MIC in our field study was 3.5mg/l, but after adaptation in
the laboratory, MIC values of 21.9mg/l were observed. Strains for which DDAC had
MICs > 1.4mg/l (“non-wildtype,” in total: 46 of 969 isolates/4.7%) were most often
found in milk and dairy products (14.6%), while their prevalence in livestock was
generally low (0–4%). Of human isolates, 2.9–6.8% had a “non-wildtype” phenotype. An
association between reduced susceptibility to DDAC, high-level-aminoglycoside resistance
and aminopenicillin resistance was seen in E. faecium (p < 0.05). No indications for a
common source of non-wildtype strains were found by RAPD-PCR; however, several
non-wildtype E. faecalis shared the same variant of the emeA-gene. In addition, bacteria
(n = 42) of different genera were isolated from formic acid based boot bath disinfectant
(20ml of 55% formic acid/l). The MICs of this disinfectant exceeded the wildtype MICs
up to 20-fold (staphylococci), but were still one to three orders of magnitude below
the used concentration of the disinfectant (i. e., 1.1% formic acid). In conclusion, the
bacterial susceptibility to disinfectants still seems to be high. Thus, the proper use of
disinfectants in livestock surroundings along with a good hygiene praxis should still be
highly encouraged. Hints to a link between antibiotic resistance and reduced susceptibility
for disinfectants—as seen for E. faecium—should be substantiated in further studies and
might be an additional reason to confine the use of antibiotics.
Keywords: disinfectant, biocide, antiseptic, antimicrobial resistance, QAC, formic acid, enterococci,
aminoglycoside
INTRODUCTION
Prevention of zoonoses—including the spread of antimicrobial
resistant bacteria—is mainly a question of how to reduce the
prevalence of contagious microorganisms. Whenever actions are
taken to reduce the spread of bacteria in livestock, effective
disinfection is crucial.
Antimicrobial resistance is basically increasing whenever resis-
tant bacteria are selected by antimicrobial use (Bronzwaer et al.,
2002; Lipsitch and Samore, 2002; Livermore, 2005). A cer-
tain antibiotic agent might directly select for resistance directed
against itself, might indirectly (cross-)select for cross-resistance
to chemically related agents and/or might (co-)select for co-
resistance to unrelated substances (Shah, 2005), the latter based
e.g., on co-transfer of resistance genes due to genetic linkage
on mobile elements. Besides co-selection posed by antibiotic
agents, diverse other co-selectors are discussed, e.g., heavy metal
ions (Berg et al., 2005; Baker-Austin et al., 2006; Hölzel et al.,
2012), pesticides (Bordas et al., 1997), or disinfectants (Levy,
2000). For several bacterial species, including methicillin resis-
tant Staphylococcus aureus, a link between resistance against
antibiotics and reduced susceptibility for disinfectants has been
described in the past (Heir et al., 1999; Bjorland et al., 2001,
2005; Sidhu et al., 2002a). At the same time, other studies
did not find clear indications for co-resistance against antibi-
otics and disinfectants (Suller and Russell, 2000; Loughlin
et al., 2002). Enterococci—apart from VRE—have rarely been
investigated for this correlation up to now, despite the fact
that enterococci are emerging—meanwhile maybe better called:
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“emerged”—nosocomial pathogens (Tailor et al., 1993; Willems
and van Schaik, 2009) with a high recombination potential
(Aarestrup et al., 2002; Leavis et al., 2006; Palmer and Gilmore,
2010; Schwaiger et al., 2011, 2012).
Acquired insusceptibility to disinfectants can be conferred by
newly acquired genes (like qac-genes, Poole, 2002) or by muta-
tions, e.g., of intrinsic multidrug transporters (like norA, emeA,
Kaatz et al., 1993; Ng et al., 1994; Jonas et al., 2001) or of target
structures (e.g., cell membranes), although the latter is described
to be a rare event with biocides (Poole, 2002). To slightly com-
plicate the situation, the mere presence of qac-genes seems to
correlate only weekly with phenotypic insusceptibility; instead,
induced overexpression of qac-genes might explain a reduced
phenotypic susceptibility in a more satisfactory way (Cervinkova
et al., 2012).
Bacteria that are contemporaneously resistant to antibiotics
and disinfectants are a worrying scenario. According to their
telling name, multidrug transporters have more than one sub-
strate (which might be chemically unrelated to each other).
In this way, multidrug transporters seem to be predisposed
to confer multiresistance. However, in most cases the unspe-
cific efflux provided by multidrug transporters leads to not
more than slightly elevated MIC-values below clinical antimi-
crobial resistance (Lee et al., 2003). Multiresistance might also
result from a combination of newly acquired genes. Such genes
can be physically linked on common genetic elements like
plasmids or transposons and might spread to other strains,
species or genera, independent from their original carriers—
as shown for qac-genes and bla-genes (Bjorland et al., 2005).
Moreover, links between antibiotic resistance and tolerance to
disinfectants might also be caused by the clonal spread of
co-resistant strains—irrespective of whether this co-resistance
is encoded within the intrinsic or within the variable gene
pool. This might be the reason why most evidence for co-
resistance to antibiotics and disinfectants is found in MRSA-
strains, which are known to spread often in clonal complexes
(Oliveira et al., 2002). Although antibiotic resistance in entero-
cocci is thought to spread mainly via the horizontal spread of
resistance genes (Willems et al., 2011), successful clonal lineages
have also been identified (Nallapareddy et al., 2005; Leavis et al.,
2006).
In case of co- or cross-resistance to disinfectants, any discus-
sion should be very carefully balanced, since adequate disinfection
is crucial for any hygienic concept (Cozad and Jones, 2003), in
hospitals as well as on farms or in the food producing indus-
try. Russell (2000) emphasizes that the term cross-resistance is
problematic for the situation seen up to now with antibiotics
and disinfectants, since all studies which report on this phe-
nomenon use disinfectant concentrations far below practically
applied concentrations. This means that, up to now, we are talk-
ing about “microbiological” or “epidemiological” resistance to
disinfectants. Such strains differ from the wildtype by elevated
MIC-values, but still have MIC-values below “clinically” or “in
praxi” used (breakpoint) concentrations.
The present study aimed to investigate a representative
number of Enterococcus faecalis (n = 824) and Enterococcus
faecium (n = 130) from diverse sources (hospital/food indus-
try/farm animals) for their susceptibility to a disinfectant
(didecydimethylammoniumchlorid, DDAC) and 22 antibiotic
agents. The distribution of strains with DDAC-MICs > or
< 1.4mg/l within antibiotic resistant and susceptible strains
was assessed. In case of elevated DDAC-MIC-values strains
were investigated for clonal relationship using amplicon-typing
(RAPD-PCR). In several isolates, the emeA-genotype, coding for a
multidrug efflux transporter, was further investigated by melting
curve analysis and sequencing.
The higher the initial MIC of strains the more rapidly they
might be adapted to rising concentrations of disinfectants, as
shown by Sidhu et al. (2002b). Therefore, we performed addition-
ally an exploratory adaptation test with the DSM 2570 reference
strain and three strains with DDAC_MICs > 1.4mg/l.
To have a first glance on real life conditions, different bacterial
species were additionally isolated from the disinfectant fluid of
boot baths and tested for their MIC-values for DDAC, formic acid
and antibiotics.
MATERIALS AND METHODS
COLLECTION AND IDENTIFICATION OF STRAINS
All Enterococcus strains (n = 954) were collected and identified
in the frame of the second Bavarian antimicrobial resistance
monitoring project (BAVMAP II, Bischoff et al., 2012) by species-
specific PCR as previously described (Bischoff et al., 2012).
Isolates from disinfectant boot bath were taken in three different
ways:
(i) By direct culturing from the disinfectant fluid.
(ii) By means of a sterile swab which was subsequently intro-
duced in TS-broth (30 g cold filterable tryptone soya broth
per 1 l of distilled water) supplemented with a specific
inactivation medium for organic acids. The inactivation
medium was recommended by the German Veterinary
Medical Society (DVG, 2008) and was added to the disinfec-
tant with final concentrations of 3% tween 80, 3% saponin,
0.3% lecithin, 0.3% sodium thiosulphate, 0.1% histidin,
0.01mol/l disodium hydrogenphosphate.
(iii) By means of a sterile swab as described above, but without
inactivation medium.
Swabs and disinfectant fluid were streaked on nutrient agar
with 7% sheep blood, on Gassner agar, CATC-agar, and
Schaedler agar; plates were incubated aerobically or anaer-
obically (Schaedler Agar) for 48 h. Single colonies were
picked, subcultured, and preliminary identified by colony
morphology, Gram staining, oxidase-, catalase-, and indole-
reaction, as well as growth and characteristics on selective
agar (Fluorocult agar, VWR, Darmstadt, Germany; CATC
agar, VWR; Baird Parker agar, Otto Nordwald, Hamburg,
Germany). Results were confirmed by commercial bio-
chemical test sets (API®/ID-32, bioMérieux, Nürtingen,
Germany; BBL™ Crystal™ Enteric/Nonfermenter ID Kit,
BD, Heidelberg, Germany) and species-specific PCR (ente-
rococci, Bischoff et al., 2012).
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SUSCEPTIBILITY TESTS
Disinfectants
Microdilution. The susceptibility of all 969 enterococcal strains
to didecyldimethylammoniumchloride (DDAC) (Tradename
Sokrena, Bode Chemie, Hamburg, Germany) was assessed in a
microdilution procedure as previously described (Bischoff et al.,
2012). In brief, TS-Broth (30 g cold filterable Tryptone Soya
Broth per 1 l distilled water) containing 1 × 108–1 × 109 cfu
of the test strain per ml was diluted 1:100 in water of stan-
dardized hardness (WSH, consisting of 0.89 g waterfree NaCl2
and 0.5 g MgCl2 × 7 H2O per 3.3:l of distilled water), result-
ing in bacterial concentrations of 1 × 106–1 × 107 cfu per ml.
Then, 100µl of a double concentrated DDAC–WSH solution
was manually placed into each well of a 96 well microtiter plate.
Thirteen ml of TS-broth was inoculated with 226µl of the 1:100
diluted bacterial suspension, and 100µl of the resulting sus-
pension was pipetted into each (DDAC-WSH filled) well of the
microtiter plate by a semiautomatic dispenser (Micronaut Sprint,
Genzyme-Virotech). Microtiter plates were covered with trans-
parent plastic films and incubated at 37◦C for 72 h, as specified
in the instructions of the German Veterinary Medical Society
(DVG, 2008); the microbial growth was visually investigated after
24 and 72 h.
Macrodilution. MIC-values > 1.4mg/l in the microdilution
test were confirmed in the DVG-reference macrodilution test.
Bacterial suspensions were prepared as for the microdilution test;
100µl of these suspensions were added to 4.9ml of TS-broth +
DDAC (DDAC-concentrations of 0.14–1400mg/l, correspond-
ing to a ready-to-use solution with 0.0002–2% = 0.002–20ml
disinfectant stock solution per liter) and incubated for 72 h.
(evaluation after 24 and 72 h) at 37◦C.
The lowest concentrated ungrown (clear) test-tube was noted
as minimum inhibitory concentration; from this tube, 0.1ml
was plated on blood agar after the 72 h of incubation in order
to determine preliminarily whether MIC-values corresponded to
minimum bactericidal (MBC)-values.
Classification. According to Bischoff et al. (2012), isolates were
classified as “non-wildtype” if DDAC had MICs > 1.4 mg/l.
This classification was additionally supported by the data of 27
enterococcal isolates from wild Finish grouse, with a range of
0.35–1.4mg/l and a median of 0.35mg/l (data not shown).
Antibiotic agents
Antibiotic resistance was determined by microdilution following
DIN 58940-81 recommendations as previously described (Hölzel
et al., 2010). All 969 enterococci were tested for antibiotic resis-
tance using a panel of 22 agents. Enterobacteriaceae from boot
bath disinfectant were tested with 13 and Gram-positives with 20
antibiotics (Table 1).
ADAPTATION TO INCREASING DDAC-CONCENTRATIONS
Four isolates of E. faecalis (E. faecalis DSM 2570 and 3 field
strains with non-wildtype MIC-values for DDAC of 2.7mg/l)
were adapted to grow in gradually increasing DDAC concentra-
tions for up to 70 days. Several colonies of the isolates were picked
from blood agar plates and were cultured in 10ml of TS-broth
(37◦C on a shaker at 200 rpm). After 24 h, 1ml suspension was
transferred into 9ml of TS-broth supplemented with DDAC
(0.7–21.9mg/l = 0.001–0.03%; starting at log 2MIC - 1) and
incubated as mentioned above for another 24 h. The adaption
process was initiated as follows: for each strain, the highest
concentrated DDAC suspension which still allowed growth
(cmax) was centrifuged. The resulting pellet was washed thrice
with WSH and homogenized. One ml of this WSH suspension
was transferred into TS-broth containing DDAC in the following
final concentrations (i) log 2 cmax − 1 (ii) log 2 cmax and (iii) log
2 cmax + 1 and incubated as mentioned above. Accompanying,
one loop-full of the inoculating suspension was streaked onto
sheep-blood-agar in order to ensure the purity of cultures. This
process was repeated every 24 h.
DNA-EXTRACTION
DNA was extracted from pure bacterial cultures of E. faecalis,
E. faecium, or E. coli using cetyltrimethylammoniumbromide
(CTAB) as previously described (Korthals et al., 2008)
RAPD-PCR
In order to investigate whether DDAC-tolerant strains were clon-
ally related, isolates were amplicon-typed by RAPD-PCR.
E. faecalis
Amplicons of E. faecalis were generated using primer M13R2:
GGAAACAGCTATGACCATGA (Martin et al., 2005). PCR-
conditions were denaturation at 95◦C for 15:00 (min:sec), fol-
lowed by 40 cycles of melting at 94◦C for 00:30, annealing at 38◦C,
01:00, elongation at 72◦C, 01:00 and a final extension step at 72◦C
for 05:00.
E. faecium
Amplicons of E. faecium were generated using primer D8635:
GAGCGGCCAAAGGGA GCAGAC (Akopyanz et al., 1992) with
two different PCR conditions (Andrighetto et al., 2001): (i) 95◦C
for 15:00 (min:sec), followed by 35 cycles of melting at 94◦C for
01:00, annealing at 47◦C, 01:00, elongation at 72◦C, 01:30 and
a final extension step at 72◦C for 10:00. (ii) Pre-PCR Cycle with
95◦C, 15:00; 40◦C, 05:00; 72◦C, 05:00, followed by 35 cycles of
94◦C, 01:00; 52◦C, 01:00; 72◦C, 02:00 and a final extension step
at 72◦C for 10:00.
INVESTIGATION OF THE emeA-GENOTYPE
All enterococci with DDAC-MICs > 1.4mg/l were previ-
ously shown to be negative for qac-genes (qac A/B, smr
[qacC/qacD], qacE1, qacG, qacJ qacH/qacZ; Bischoff et al.,
2012); one of the isolates was a qacA/B-negative variant
of a strain which was previously shown to harbor qacA/B
(Bischoff et al., 2012). Since emeA, a multidrug efflux pump
with sequence homology to the staphylococcal norA gene, is
suspected to contribute to reduced disinfectant susceptibil-
ity, 44 E. faecalis-isolates (E. faecalis DSM 2570; eight study
strains with MIC less or equal 1.05 and 35 study strains
with MIC > 1.4) were investigated for their emeA-genotype
using primers emeA-fw GACTCAACGAGTGTTTCAGCCAA and
emeA-rv ACGATAAAAAGCCCGTTCCTA as suggested by NCBI
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Table 1 | Antibiotic agents, concentration ranges, and breakpoints.
Name of antibiotic Range (mg/l) Breakpoint (mg/l) Tested against References
S≤ R >
Amoxicillin/Clavulanic acid 1/2–128/20.125/2–8/2 84 88 Gram-neg.Gram-pos. EUCAST
Ampicillin 1/2–128/20.125/2–8/2 84 88 Gram-neg.Gram-pos. EUCAST
Cefaclor 1–8 1 4 Gram-neg. DIN1
Cefazolin 0.125–16 4 8 Gram-neg. Gram-pos. DIN
Cefoxitin 2–16 4 8 Gram-neg. DIN
Cefuroxime 0.5–641–8 84 88 Gram-neg.Gram-pos. EUCASTDIN
Chloramphenicol 2–64 16 16 Enterococci DANMAPa
Ciprofloxacin 0.0625–80.25–32 0.51 12 Gram-neg. Gram-pos. EUCASTDIN
Clindamycin 0.0625–8 1 4 Gram-pos.b DIN
Doxycycline 0.5–40.125–16 1 4 Gram-neg. Gram-pos. DIN
Enrofloxacin 0.0625–8 0.25 2 Gram-neg. Gram-pos. CLSI
Erythromycin 0.0625–8 1 4 Gram-pos. DIN
Florfenicol 2–642–32 16 16 Gram-neg.Gram-pos. DIN
Fosfomycin 8–64 32 32 Gram-pos. EUCASTc
Gentamicin 0.25–32 21 41 Gram-neg.Gram-pos. EUCASTEUCASTc
Gentamicin HLd 512 512 512 Enterococci DANMAP
Imipenem 0.125–16 24 88 Gram-neg.Gram-pos. EUCAST
Linezolid 0.125–16 4 4 Gram-pos. EUCAST
Meropenem 0.125–16 2 8 Gram-neg. EUCAST
Mezlocillin 2–256 4 16 Gram-pos. DIN
Moxifloxacin 0.0625–8 1 2 Gram-pos. DIN
Rifampicin 0.5–4 0.006 0.5 Gram-pos. EUCASTb
Streptomycin HLd 256–2048 512 512 Enterococci EUCAST
Synercid 0.125–16 1 4 Gram-pos.a EUCAST
Teicoplanin 0.25–32 2 2 Gram-pos. EUCAST
Tobramycin 0.25–32 2 4 Gram-neg. EUCAST
Tylosin 0.5–4 4 4 Gram-pos. DANMAP
Vancomycin 0.5–64 4 4 Gram-pos. EUCAST
aDIN: DIN 58940-4; DANMAP: all DANMAP 2004, except tylosin: DANMAP 1997 (http://www.danmap.org/).
bExcept E. faecalis.
cFor staphylococci.
d High level concentrations indicative for aminoglycoside/penicillin synergism.
Primer Blast. PCR-conditions were denaturation at 94◦C, 05:00
(min:sec), followed by 30 cycles of melting at 94◦C, annealing at
63◦C, 01:00, elongation at 72◦C, 01:00 and a final extension step
at 72◦C, 05:00.
Melting curve analysis
Amplicons were investigated by conventional melting curve anal-
ysis under the following conditions: step 1: 95◦C, slope 20◦C/sec;
step 2: 65◦C, hold-time 30 s., slope 20◦C/sec; step 3: 95◦C, slope
0.1◦C/sec. Delta Tm was recorded as follows: Tm (wildtype)
minus Tm (variant), with Tm = temperature at the maximum
value for -d(F1)/dT (maximum of the melting peak). Peaks were
suspected to be different if Delta Tmwas at least 0.6◦C. A diversity
of peaks was further investigated by sequence analysis.
Sequence analysis
DSM-reference strain E. faecalis DSM 2570 (ATCC 29212),
for which an emeA-sequence is already recorded in Genbank
(AB091338.1 GI:22775586) and three emeA-amplicons of study
isolates were externally sequenced (Sequiserve, Vaterstetten,
Germany). Sequences were compared with each other and with
nucleotide records—including nine emeA-sequences of E. fae-
calis—in Genbank using the default NCBI-BLAST-program for
highly similar sequences.
Relative transcription of emeA-variants
The transcription of emeA in relation to the transcription
of DNA coding for a partial sequence of the 23S-rRNA
was investigated by RT-PCR as previously described
(Schwaiger et al., 2012), using the emeA-primers as described
above and primers GTAGTCCACAGCTTCGGTAATATGT
and AACTAGGATGTTGGCTTAG AAGCA for a 23S-
rDNA-fragment as described elsewhere (Hancock
et al., 2003). For a preliminary impression, differ-
ences in gene transcription were calculated using the
2∧-DeltaDeltaCt-method.
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STATISTICS
The prevalence of DDAC-MICs > 1.4mg/l within the groups of
antibiotic resistant and antibiotic susceptible E. faecalis and E.
faecium was assessed in a chi-squared test. If expected numbers
per cell were below five, a Fisher’s Exact test was applied. A non-
parametric procedure (Mann–Whitney U) was used to compare
the MIC-values of DDAC as well as the MIC-values of antibiotics
in strains with different emeA-types.
RESULTS
SUSCEPTIBILITY OF E. faecalis AND E. faecium TO DDAC AND
ANTIBIOTICS
MIC-values for DDAC
MIC-values for DDAC differed from wildtype-MIC-values only
in a small fraction of E. faecalis or E. faecium (Table 2), and only in
a very moderate way (Table 3). The highest prevalence of DDAC-
MICs > 1.4mg/l was seen in enterococci from milk and dairy
products (14.5%), while the prevalence in livestock was gener-
ally low (0–4%). Themaximummultiplication ofMIC-values was
3.3-fold (1.05 vs. 3.5mg/l).
All “non-wildtype” MIC-values for DDAC (> 1.4mg/l) were
confirmed in the macrodilution test.
MBC-values did not exceed the MIC-values in any case
(MBC = MIC in 44/44 isolates).
Adaptation to increasing DDAC-concentrations
All isolates which were used in the adaptation test were adapted
to grow in higher concentrations (up to 21.9mg/l) during 70
days of adaptation. Despite DDAC-MIC-values of 2.7mg/l at the
beginning, three human E. faecalis strains were not adapted to
higher concentrations than the E. faecalis DSM 2570 strain with
an initial DDAC-MIC-value of 0.7mg/l (Figure 1): at day 5 of
the adaptation experiment, DSM 2570 reached the same level as
the non-wildtype strains. The DDAC-MIC-value for DSM 2570
increased further on day 6, while the non-wildtype strains had
DDAC-MIC-values of 2.7mg/l until day 22; all strains (includ-
ing the DSM-strain) had DDAC-MICs of 21.9mg/l (4.45 log2)
on day 71.
MIC-values for antibiotics
The fraction of DDAC-MICs < 1.4mg/l or > 1.4mg/l within
gentamicin/streptomycin-high-level- and ampicillin-resistant
or -susceptible strains of E. faecalis and E. faecium is shown
in Table 2. No significant differences were found for E.
faecalis—neither for these substances, nor for any of the
other investigated antibiotics (data not shown). However,
for human hospital-derived E. faecium a Fisher’s Exact Test
revealed that DDAC-MICs > 1.4 mg/l Enterococcus were
significantly (p < 0.05) more prevalent in streptomycin-
high-level-resistant isolates: Of the clinical isolates, 1 out
of 75 streptomycin-susceptible strains (1.3%) vs. 4 out of
22 streptomycin-resistant strains (18.2%) were inhibited by
DDAC-concentrations > 1.4mg/l. Significantly elevated preva-
lences of isolates with DDAC-MICs > 1.4mg/l were also seen
within clinical gentamicin- and ampicillin-resistant isolates
(Table 2).
Table 2 | Prevalence of E. faecalis and E. faecium with DDAC-MICs > 1.4 mg/l within antimicrobial-susceptible and –resistant isolates of
different sources.
Source Prevalence of strains with DDAC-MICs > 1.4mg/l (n) within all investigated isolates (N)
Total Total% GNHa GNH SNHb SNH AMPc AMP
susceptible resistant susceptible resistant susceptible resistant
E. faecalis
Hospital: human blood 6 (88) 6.8 6 (62) 0 (26) 5 (60) 1 (28) 6 (85) 0 (3)
Hospital: human feces 8 (210) 3.8 7 (144) 1 (56) 6 (177) 2 (33) 8 (210) 0 (0)
Outpatient feces 3 (102) 2.9 3 (94) 0 (8) 3 (96) 0 (16) 3 (102) 0 (0)
Swine, feces 0 (76) 0.0
Cattle, feces 0 (50) 0.0
Cattle, matistis milk 0 (50) 0.0
Chicken, feces 2 (50) 4.0 2 (48) 0 (2) 2 (46) 0 (4) 2 (50) 0 (0)
Milk and dairy products 14 (96) 14.6 13 (95) 1* (1) 14 (95) 0 (1) 2 (96) 0 (0)
Poultry 2 (54) 3.7 2 (54) 0 (0) 2 (43) 0 (11) 2 (54) 0 (0)
Beef 3 (30) 10.0 3 (30) 0 (0) 3 (29) 0 (1) 3 (30) 0 (0)
Pork 1 (28) 3.6 1 (26) 0 (2) 1 (25) 0 (3) 1 (28) 0 (0)
E. faecium
Hospital: human blood 3 (45) 6.7 1 (31) 2 (14) 1 (32) 2 (13) 0 (7) 3 (38)
Hospital: human feces 2 (52) 3.8 0 (42) 2* (10) 0 (43) 2* (9) 0 (38) 2* (14)
Outpatient: feces 2 (38) 5.3 2 (38) 0 (0) 2 (36) 0 (2) 2 (37) 0 (1)
aGNH gentamicin (high level).
bSNH streptomycin high level.
cAMP ampicillin.
*Differs significantly in a Fisher’s Exact Test from the overall prevalence in this study, p < 0.05.
Bold: emphasized for the sake of clarity
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Table 3 | Minimal inhibitory concentrations and antimicrobial resistance of antiseptic-tolerant (MIC > 1.4mg DDAC/l) Enterococcus isolates.
Species Source n Range MIC DDAC emeA-type qac-gene* Resistotype
(mg/l, 8-fold assay;
0.7mg/l = 0.001%)
E. faecalis Hospital: 1 2.1 1 – CIP ENR LEV MOX DOX ERY TLS TEL SNH
Human blood 1a 2.1 2 – DOX ERY
1a 2.45–3.5 n.d. qacA/B+1 DOX ERY
1.75 2 qacA/B− DOX ERY
1 1.05–>1.4** 1 – DOX
2 2.1 0 – –
Human feces 1 1.75 0 – CIP ENR LEV MOX ERY TLS TEL GNH SNH
1 2.45–3.5 n.d. – DOX ERY SNH
1 1.75 2 – DOX ERY TLS
1b 1.75 1 – DOX ERY
1 2.1 0 – DOX
1 1.75 0 – –
1b 2.8–3.5 2 – –
1b 3.5 1 – –
Outpatients: 1 2.1 2 – DOX ERY
Human feces
1 2.1–2.45 2 – –
1 2.45–3.5 2 –
Animal: 2 1.05–1.75 1/0 – –
Chicken
Milk and dairy products 1 1.75 1 – ERY TLS TEL GNH
2 2.1 0 2 – ERY
3 1.75 n.d. /1 – –
1 1.75–2.1 /0 –
1 2.1 x
5 2.1–2.45 x/1/2/0/0 –
1 2.1–3.5 2 –
1 2 –
Meat: 1 1.05–>1.4** 0 – –
Poultry 1 2.1 1 –
Beef 1 1.75 0 – ERY
1 1.75 2 – –
1 2.1 2 – –
Pork 1 2.1 2 – ERY
E. faecium Hospital: 1 1.75 n.d. – AMC AMP MZL IMP MER CIP ENR LEV MOX ERY
Human blood TLS TEL GNH
1c 1.75 n.d. – AMC AMP MZL IMP MER CIP ENR LEV MOX ERY
TLS TEL SNH
1c 1.75 n.d. – AMC AMP MZL IMP MER CIP ENR LEV MOX ERY TLS
TEL SNH GNH
Human feces 1d 1.75 n.d. – AMC AMP MZL IMP MER CIP ENR LEV MOX ERY
TLS TEL SNH GNH
1d 1.75 n.d. – AMC AMP MZL IMP MER CIP ENR LEV MOX ERY TLS
TEL SNH GNH
Outpatients: 1e 1.05–>1.4** n.d. – ERY TLS LIZ
Human feces
Healthy humans:
1e 1.4–>1.4** n.d. – CIP ENR ERY
1 2.8 n.d. n.d. CIP ENR DOX GNH
1(Bischoff et al., 2012).
a,b,c,d Originating from different patients of the same hospital in the same period of investigation, respectively; eisolates of two different outpatients, sent in from
the same laboratory in the same period of investigation.
DDAC, Didecyldimethylammoniumchloride; AMC, Amoxicillin + Clavulanate; AMP, Ampicillin; MZL, Mezlocillin; IMP, Imipenem; MER, Meropenem; CIP, Ciprofloxacin;
ENR, Enrofloxacin; LEV, Levofloxacin; MOX, Moxifloxacin; ERY, Erythromycin; TLS, Tylosin; TEL, Telithromycin; GNH, Gentamicin High Level; SNH, Streptomycin
High Level; LIZ, Linezolid.
*Investigated qac-genes: qacA/B, qacC, qacD, qacE1, qacG, qacH/qacZ, qacJ. **DDAC-tolerance was reproduced twice, but not at the third time.
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FIGURE 1 | MIC-values (log2) of didecyldimethylammoniumchloride
(DDAC) in E. faecalis with initial MICs > 1.4mg/l, compared with
control DSM 2570 during 70 days of stepwise adaptation.
FIGURE 2 | Amplicon-typing (RAPD-PCR) of E. faecalis (MIC of
DDAC > 1.4mg/l) from different sources.
PHYLOGENETIC DIVERSITY OF STRAINS WITH DDAC-MIC> 1.4mg/l
In order to reveal whether enterococci with DDAC-MICs >
1.4mg/l belonged to one or more clonal lineages, the phyloge-
netic diversity of the study isolates with DDAC_MIC > 1.4mg/l
was investigated by RAPD-PCR. The investigated strains of E. fae-
calis belonged to at least three distinct RAPD-types. However,
compared to the completely distinct RAPD-profile of the ref-
erence strain, profiles of strains with DDAC-MIC > 1.4mg/l
were more similar, indicating a certain degree of phylogenetic
relatedness, but no clonality (an example is given in Figure 2).
One identical RAPD-profile was shared by one isolate from
human blood, from poultry and from poultry meat, respectively
(Figure 2).
The RAPD-profiles of E. faeciumwith DDAC-MICs> 1.4mg/l
were similar for the fecal isolates including the (wildtype) DSM
type strain, but differed from the bloodstream isolate (Figure 3).
emeA-GENOTYPE IN E. faecalis WITH DDAC-MICS> 1.4 mg/l
Melting curve analysis
Conventional melting curve analysis of E. faecalis-emeA-
amplicons resulted in two clearly distinguishable peaks (type 1
FIGURE 3 | Amplicon-typing (RAPD-PCR, two different conditions) of E.
faecalis (MIC of DDAC > 1.4mg/l) from different sources.
and 2, Figure 4) at approximately 87and 86◦C with Delta Tm =
0.9 ± 0.3◦C). Of all investigated isolates, 12 could be clearly
attributed to type 1 and 13 could be clearly attributed to type 2
(Table 3). The other isolates had a Delta Tm which could not be
unambiguously assigned to one of both types (type 0) or had a
Tm higher than type 1 (type x). E. faecalis DSM 2570 represented
the prototype for the higher Tm-value (type 1). This strain and
three prototypes for the lower Tm value (type 2) were exter-
nally sequenced. Results of a sequence comparison using NCBI-
Primer-Blast are given in Table 4. The amplicon of DSM 2570
was completely identical to the corresponding sequence of DSM
2570 = ATCC 29212 recorded in Genbank by Lee et al. (2003)
(Accession AB091338). The amplicons of the three sequenced
study-strains differed from this sequence in 9 nucleotides;
they matched two other recorded Genbank-sequences: E. fae-
calis D32 (Accession CP003726) and E. faecalis 62 (Accession
CP002491).
All differences between the DSM-strain and the sequenced
study strains (as well as D32 and 62) were synonymous substi-
tutions which do not affect the sequence of amino acids.
The median DDAC-MIC-value for investigated isolates with
type 1 melting curves was 1.5 (1.05–3.5)mg/l, the median MIC
for isolates with type 2 melting curves was 2.1 (1.75–3.2)mg/l,
resulting in a significant difference in a non-parametric test
(Mann–Whitney U, p < 0.01). Of eight investigated wildtype
strains (MIC < 1.4mg/l), none was attributed to melting type 2
(Table 3).
The number of phenotypic antibiotic resistances was 0–3 in
isolates with emeA-type 2 and 0–9 in type 1 isolates. The median
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MIC-values of antibiotics differed only insignificantly between
isolates of both melting types (Mann–Whitney U, p > 0.05).
Relative transcript level for two different emeA-variants
In relation to the basal transcription of DNA coding for a par-
tial sequence of the 23 s rRNA, relative transcript levels for
emeA-variants of type 2 were on average slightly higher than
for emeA-variants of type 1 (mean 2∧-DeltaDeltaCt = 5.78).
2∧-DeltaDeltaCt-values (type 2 vs. type 1) ranged from 0.2 to
314.5. The maximum of 2∧-DeltaDeltaCt-values within type 1
was 116.4, themaximum of 2∧-DeltaDeltaCt-values within type 2
was 13.9, indicating a higher homogeneity in emeA-transcription
within the type-2-group.
ISOLATION OF BACTERIA FROM DISINFECTANT BOOT BATH (ACTIVE
INGREDIENT: 1.1% FORMIC ACID)
Bacterial identification
From boot bath disinfectant (1.1% formic acid), 42 bacte-
rial strains were isolated and differentiated (Table 5). E. coli
(n = 7) was only isolated from swabs substituted with inacti-
vation medium. Other Enterobacteriaceae (Providencia rettgerie,
Acinetobacter lwoffi, Enterobacter cloacae) were also isolated with-
out this inactivation step. Gram-positive cocci (staphylococci
FIGURE 4 | Conventional melting curve analysis (Lightcycler I.I,
SYBR-Green) of emeA-amplicons resulting in two different emeA
types: type 1 (higher Tm) and type 2 (lower Tm).
and enterococci) were found in all kinds of sample including
the disinfectant solution, although the latter was predominantly
positive for Bacillus spp.
MIC-values for formic acid and DDAC
MIC-values for the formic acid based disinfectant were 0.003–
0.14% and thus below the used concentration of 1.1% formic
acid, indicating that the isolated bacteria were not able to replicate
in the disinfectant boot bath. In general, Gram-negative bacte-
ria had higher MIC-values for formic acid (0.03–0.14%, median
0.14%) than Gram-positive bacteria (0.003–0.07%, median
0.01%). Besides one isolate, all strains had MIC-values com-
parable to a DSM reference strain of the same genus; one S.
saprophyticus strain had a MIC of 0.07%, while S. aureus (DSM
1104) and one non-hemolytic S. aureus from the disinfectant fluid
had MIC-values of 0.003% formic acid. MIC-values for DDAC
ranged from 1.4 to 21.9mg/l (0.002–0.03% concentrate, median:
0.008%) in Gram-negatives, with the highest values seen in P.
rettgerie and E. cloacae, while A. lwoffii was the most suscepti-
ble Gram-negative strain. In Gram-positives, DDAC-MIC-values
were 0.7–21.9mg/l (0.001–0.03% concentrate, median: 0.008%),
with the highest values seen in one of the three B. licheniformis
isolates. E. faecalis and E. faecium isolates from disinfectant boot
bath (active agent: formic acid) had non-wildtype MICs (0.008%
or 5.6mg/l) for DDAC.
Natural or acquired resistance to antibiotics
Of 42 strains isolated from disinfectant boot bath, 9 (21.4%,
including E. coli) were resistant to amoxicillin + clavulanate,
5 (11.9%) to ciprofloxacin, 6 (14.3%) to doxycycline and 2
(4.8%) to tobramycin. P. rettgerie was multiresistant (amoxi-
cillin + clavulanate, doxycycline, tobramycin). Bacillus cereus
group isolates were intrinsically resistant to amoxicillin + clavu-
lanate; other Bacillus isolates (B. licheniformis, n = 3, uniden-
tified Bacillus sp.) were resistant to clindamycin, erythromycin
and telithromycin, or to clindamycin only (B. megaterium). No
antibiotic resistance was found in B. pumilus and B. subtilis.
DISCUSSION
Reports on a link of antibiotic resistance and reduced sus-
ceptibility to disinfectants are inconsistent: Russell concluded
from his review that “bacteria showing reduced susceptibility
to biocides may or may not be more resistant to antibiotics”
Table 4 | Polymorphism analysis (NCBI BLAST) of emeA-amplicons as sequenced in the present study.
Source MIC-value (mg/l) Melting type Polymorphic nucleotides
Goulash (pork) 2.0 1 _141G_251G*_305G_311T_320 T_392T_402G_407T_431T_479A_491T_551
T_560T_563a_572g_779T_855T_
Whipped cream 2.2 1 Sequence as above
Child (gastro-intestinal disorder) 2.7 1 Sequence as above
DSMZ (urine) 1.05 2 _141G_251A_305G_311C_320G_392T_402G_407G G_491T_551A_560T_563
a_572g_779C_855C__431C_479
Bold letters: differ from DSM 2570. Other letters: identical with DSM 2570 but variable in other E. faecalis-emeA-entries in the Genbank database. _ spacer for
conserved regions in all genbank entries. *Unique variant not seen in any other genbank-entry.
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Table 5 | Antimicrobial resistance and susceptibility to disinfectants of bacteria isolated from boot bath disinfectant (2% concentrate = 1.1%
formic acid).
Source/Identity MIC formic MIC DDAC-stock solution Acquired resistance Natural resistance
acid in % (7g/100g) in % profile profile
SWAB (AFTER INACTIVATION)
Bacillus cereus group 0.006 0.001 CIP FOS CEC
Enterococcus hirae 0.003 0.008 CLI ERY ROX TYL DOX MZL MER
Staphylococcus
saprophyticus
0.07 0.004 TYL –
Escherichia coli (n = 2) 0.14 0.008 – GN2
Escherichia coli 0.14 0.008 DOX GN
Escherichia coli 0.14 0.008 CEC GN
Escherichia coli (n = 2) 0.14 0.008 DOX CEC GN
Escherichia coli 0.14 0.008 AMC GN
Escherichia coli ß-D-Gluc.
neg (n = 2)
0.14 0.008 – GN
Citrobacter freundii 0.14 0.008 – GN + AMC CEC CEZ COX CXM
Lactose-neg.
Enterobacteriaceae
n.d. >0.01 CEC DOX ENR FOS
SWAB (NO INACTIVATION)
Unidentified, double-zone
hemolytic obligate
anaerobe
n.d.1 n.d.1 n.d.1 n.d.
Unidentified
Gram-negative
n.d. n.d. GN + AMC CEC CEZ CXM CIP
Enterobacter cloacae 0.14 0.03 FOS GN + AMC CEC COX CEZ CXM
Citrobacter sp. n.d. >0.01 – GN
Citrobacter freundii 0.14 0.008 – GN + AMC CEC CEZ COX CXM
Klebsiella oxytoca n.d. >0.01 CEZ FOS GN
Acinetobacter lwoffi 0.06 0.002 FOS GN + AMC CEC CEZ COX CXM
Providencia rettgerie 0.14 0.03 AMC CEC CEZ FOS DOX TOB GN
Providencia rettgerie 0.14 0.03 FOS DOX TOB GN
Moraxella sp. n.d. >0.01 – GN + AMC CEC CEZ COX CXM
DISINFECTANT FLUID
Bacillus cereus group 0.003 0.001 – AMC CEC CEZ COX CXM OXA PEN
Bacillus licheniformis
(n = 3)
0.01 0.002–0.03 CLI ERY TEL FOS CXM OXA PEN
Bacillus subtilis group n.d. >0.01 – FOS
Bacillus megaterium 0.006 0.001 – FOS CLI
Bacillus pumilus 0.003 0.001 – –
Clostridium perfringens 0.003 0.008 n.d. n.d.
Enterococcus faecium
(n = 2)
0.02 0.008 CLI ERT FOS MER MOX
Enterococcus faecalis
(n = 2)
0.01 0.008 ERY TLS CLI SYN
Staphylococcus aureus 0.003 0.008 – –
1No growth in TS-broth, CAMHB, and Wilkens Chalgren broth in aerobic or anaerobic conditions.
2GN: natural resistance to antibiotics which are ineffective in Gram-negatives like benzylpenicillin, macrolides, lincosamides, streptogramins.
DDAC, Didecyldimethylammoniumchloride; AMC, Amoxicillin + clavulanate; AMP, Ampicillin; CEC, Cefaclor; CEZ, Cefazolin; CIP, Ciprofloxacin; COX, Cefoxitin; CXM,
Cefuroxime; FOS, Fosfomycin; DOX, Doxycycline; MER, Meropenem; ENR, Enrofloxacin; ERT, Ertapenem; ERY, Erythromycin; LEV, Levofloxacin; MOX, Moxifloxacin;
TLS, Tylosin; TEL, Telithromycin.
(Russell, 2002). This might be due to species-specific differ-
ences, since many of the studies which report such a link are
related to staphylococci (Zmantar et al., 2011). Since entero-
cocci have rarely been representatively investigated up to now,
this study aimed to provide completing data. The investigated
disinfectant—a quaternary ammonium compound, DDAC—is
used in every relevant context (food-producing environment,
livestock, clinical settings) and listed by the German Veterinary
www.frontiersin.org March 2014 | Volume 5 | Article 88 | 9
Schwaiger et al. Link of biocide insusceptibility and antimicrobial resistance
Medical Society (DVG, 2008) as well as the German Association
for Hygiene and Microbiology (DGHM), which are the most
important reference institutions for recommending disinfectants
in Germany. Recommended concentrations of the stock solution
in the ready to use fluid range from 0.5 to 4% (350–2800mg
DDAC/l).
None of the investigated Enterococcus isolates—whether
antibiotic resistant or not—was able to grow in a DDAC concen-
tration recommended for in praxi use (0.5%= 5ml stock solution
per liter; stock solution = 7 g DDAC/100 g). However, since dis-
infectants are applied to frequently cleaned environments, rinsing
might shape environmental niches with low concentrations of
disinfectants. This is especially true in case of improper use
(e.g., application to wet surface), but might also happen with
proper use, since DDAC is non-volatile and stable to hydroly-
sis (Juergensen and Busnarda, 2000). Thus, wastewater disposal
lines might provide permanent contact between bacteria and
low concentrations of disinfectants. The same might be true
for biofilm-associated bacteria in production lines like milklines.
Relating to this, it might be interesting that the prevalence of
DDAC-MICs > 1.4mg/l was comparatively high in enterococci
from dairy products.
The maximum observed MIC in our field study was 3.5
(0.005%), but after 70 days of adaptation in the laboratory, MICs
of 21.9 mg/l (0.03%) were observed. Thus, permanent contact
to low concentrations of disinfectants might considerably lower
the susceptibility for these disinfectants. However, in the present
study we could not substantiate that bacteria with higher initial
MIC-values are more rapidly adapted to rising concentrations of
QACs, as observed by others (Sidhu et al., 2002a,b).
With the macrodilution test followed by plating, we could not
find differences between the minimum inhibitory and minimum
bactericidal concentration of enterococci. Russell (2003) empha-
sizes that testing for lethal effects is superior to MIC-testing
when assessing the effectiveness of disinfectants. This statement is
underlined by the fact that Gram-negative bacteria are regularly
reported to have higher MIC-values for disinfectants (Russell,
2001), suggesting lower susceptibility; however, at the same time,
they might have lower MBC-values: Walsh et al. (2003) report
that equal concentrations of a DDAC did more effectively reduce
E. coli (but not Pseudomonas spp.) than S. aureus. Indeed, we
could isolate Gram-positive cocci directly from 2% boot bath
disinfectant fluid, while we did not find Gram-negatives in
there.
In contrast to the expectation of higher disinfectant-MIC-
values in Gram-negatives, in this study we found an identical
maximumDDAC-MIC in Gram-positives (one of three B. licheni-
formis) and Gram-negatives (E. cloacae, P. rettgerie), as well as
identical median values; only the minimum DDAC-MIC value
was one log2-step lower in Gram-positives. However, MICs of
formic acid were consistently higher in Gram-negatives.
Isolation of bacteria from disinfectant fluid does not neces-
sarily mean that the disinfectant is ineffective, since the in praxi
bacterial inoculum (and therefore the log10-reduction, for which
several guidelines set the critical limit at greater than or equal to
5, e.g., BS EN 1276) was unknown. As long as bacteria do not
reproduce, they are not enriched in the disinfectant fluid. Formic
acid inhibited growth (=reproduction) of all bacteria isolated
from boot bath disinfectant (1.1% formic acid) at concentra-
tions = 0.14% in clean conditions. However, any disinfectant
vanishes with time (or rinsing), and the protection of certain
bacteria (while others are killed) will indeed affect the bacterial
community in a post-disinfection environment (McBain et al.,
2004). Thus it should be mentioned that we isolated E. coli with
a derepressed AmpC-phenotype from the disinfectant boot bath,
as well as multiresistant P. rettgerie. However, these isolates were
accompanied by susceptible isolates of the same species (and
thus ecological niche), and the E. coli were only found after an
inactivation step.
Although all formic acid MIC-values were below the used con-
centration, one S. saprophyticus strain had a MIC-value of 0.07%,
which was eye-catching compared to the S. aureus isolates with
a MIC-value of 0.003%. Thus, high MIC-values might indeed
be also indicative for an enhanced ability to survive in disinfec-
tant surroundings (elevated MBC-values), even for structurally
unrelated substances. However, vice versa low MIC-values do not
exclude high MBC-values (Russell et al., 1999).
The presence of four Enterococcus isolates (two E. faecalis,
two E. faecium) with non-wildtype MICs for DDAC is inter-
esting, remembering the very low prevalence of such strains
within these two species (e.g., E. faecalis: 0/50 porcine isolates)
as seen in the representative DDAC-MIC-screening. The selec-
tion of such strains in a chemically completely distinct agent
might be indicative that these enterococci use an unspecific way
to reduce their susceptibility to chemical agents. Indeed, disin-
fectant resistance in enterococci has been linked to multidrug
efflux pumps before (Poole, 2002). Since we investigated the
E. faecalis isolates which showed DDAC-MICs > 1.4mg/l in
the screening nearly in vain for qac-genes (only four of 586
strains were positive, Bischoff et al., 2012), we had a closer
look on the emeA-genotype, and noticed a variability of this
emeA-genotype in a conventional melting curve analysis (verified
by sequencing). However, strains with DDAC-MICs > 1.4mg/l
could not be consistently linked to one emeA-type, although
the MIC-values of type 2 were statistically significantly higher
than the MIC of type 1 and type 2 melting curves were absent
in wildtype strains. The only difference between type 2 and
the DSM-reference-strain (type 1) were nine synonymous sub-
stitutions. Thus, we do not assume that these substitutions
affected the activity of the multidrug transporter. However, Berg
and Martelius stated that an increase in synonymous substitu-
tions might be caused by differences in gene expression (Berg
and Martelius, 1995). Indeed, when we had a first glance at
the mean relative transcript-levels of the two different emeA-
variants, the relative transcript-levels for type 2 with the higher
meanMIC-value was slightly (but insignificantly) higher. Further
investigations on the gene expression level would be needed
to verify this tendency, and further analysis of the promoter
region might elucidate the cause for an enhanced transcription
of emeA.
Multidrug efflux transporters of the emeA-type would only
partially explain disinfectant-antibiotic “cross-resistance,” since
they induce no or only minor changes in MIC-values for sev-
eral antibiotics which were present in the multidrug resistant
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phenotypes of our isolates, like tetracyclines, macrolides or even
fluoroquinolones (Lee et al., 2003). Interestingly, the number of
phenotypic antibiotic resistances was 0–3 in isolates with emeA-
type 2, but 0–9 in type 1 isolates, giving reason for ongoing
investigations of a transferable nature of DDAC-non-wildtype
phenotypes in the multiresistant isolate, due to another mecha-
nism which is not related to emeA.
One multiresistant E. faecalis isolate mentioned above had
a resistance profile similar to multiresistant E. faecium isolates
(including gentamicin high level resistance and streptomycin high
level resistance). For these E. faecium isolates, a statistically signif-
icant association of DDAC-MICs> 1.4mg/l and gentamicin high
level resistance, streptomycin high level resistance, and ampi-
cillin resistance was seen. While E. faecium isolates (MIC DDAC
> 1.4mg/l) from the same source (human feces), but different
institutions, had similar RAPD-types, the RAPD-type of an E.
faecium from human bloodstream (MIC DDAC > 1.4mg/l) dif-
fered substantially from the others. This indicates that the isolate
was not clonally related to the other isolates and thus suggests
another reason for congruent resistance phenotypes (like identi-
cal multiresistance plasmids). However, we could not prove the
transferability of the phenotype or the presence of multiresis-
tance plasmids up to now. It should also be mentioned that the
“multiresistant + DDAC-tolerant”-phenotype was only found in
few isolates from clinical settings, not in outpatients. However,
the only gentamicin high level resistant E. faecium isolate which
we found in healthy humans (1/32) also had a DDAC-MIC >
1.4mg/l (data not shown).
CONCLUSIONS
Resistance to in-praxi-concentrations of disinfectants still seems
to be rare or even absent in livestock- or food-associated bacteria.
This study gives some indication of a link between antibiotic resis-
tance and (moderate) tolerance to disinfectants in a constrained
number of isolates. Up to now the main driving force for the
spread of such co- or cross-tolerant strains would be the use of
antibiotics, not of disinfectants: selective advantage against dis-
infectants for the biocide-tolerant strains would be restrained to
environmental niches (e.g., wastewater disposal lines), due to the
fact that the moderately increased disinfectant-MIC-values were
still far below disinfectant concentrations used in praxi. Thus,
proper use of disinfectants in livestock surroundings still should
be highly encouraged, as long as it is accompanied by general
good hygiene praxis.
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